Placebo Shampoo

OTHER3 trials

Sponsors

Arbor Life Labs, Fakultas Kedokteran Universitas Indonesia

Conditions

Androgenetic AlopeciaAndrogenic AlopeciaHair Loss/BaldnessHair ThinningPityriasis VersicolorTelogen EffluviumThinning Hair

Phase 4

Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor

Not yet recruitingNCT07471178

Fakultas Kedokteran Universitas IndonesiaPityriasis Versicolor

Start: 2026-02-01End: 2026-06-01Target: 76Updated: 2026-03-13

Unknown Phase

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss

CompletedNCT04450589

Arbor Life LabsAndrogenetic Alopecia, Androgenic Alopecia, Hair Loss/Baldness +3

Start: 2018-04-11End: 2018-10-23Updated: 2020-06-30

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss

CompletedNCT04450602

Arbor Life LabsAndrogenetic Alopecia, Androgenic Alopecia, Hair Loss/Baldness +3

Start: 2018-04-03End: 2018-10-23Updated: 2020-06-30

Related Papers

Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.

2021-09-115 citations

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.

2021-06-2410 citations